17 alpha-hydroxylase deficiency differential diagnosis: Difference between revisions
No edit summary |
No edit summary |
||
Line 38: | Line 38: | ||
|Normal | |Normal | ||
|Normal | |Normal | ||
|XY and XX | |[[XY]] and [[XX]] | ||
|- | |- | ||
|[[17-alpha-hydroxylase deficiency]] | |[[17-alpha-hydroxylase deficiency]] | ||
Line 55: | Line 55: | ||
|Normal | |Normal | ||
|Normal | |Normal | ||
|XY | |[[XY]] | ||
|- | |- | ||
|[[Gonadal dysgenesis]] | |[[Gonadal dysgenesis]] | ||
Line 70: | Line 70: | ||
|High | |High | ||
|High | |High | ||
|XY | |[[XY]] | ||
|- | |- | ||
|[[Testicular regression syndrome]] | |[[Testicular regression syndrome]] | ||
Line 82: | Line 82: | ||
|High | |High | ||
|High | |High | ||
|XY | |[[XY]] | ||
|- | |- | ||
|[[LH receptor|LH receptor defects]] | |[[LH receptor|LH receptor defects]] | ||
Line 99: | Line 99: | ||
|High | |High | ||
| | | | ||
|XY | |[[XY]] | ||
|- | |- | ||
|[[5-alpha-reductase deficiency|5-alpha-reductase type 2 deficiency]] | |[[5-alpha-reductase deficiency|5-alpha-reductase type 2 deficiency]] | ||
Line 116: | Line 116: | ||
|High to normal | |High to normal | ||
| | | | ||
|XY | |[[XY]] | ||
|- | |- | ||
|[[Androgen insensitivity syndrome]] | |[[Androgen insensitivity syndrome]] | ||
Line 129: | Line 129: | ||
| | | | ||
| | | | ||
|XY | |[[XY]] | ||
|- | |- | ||
|[[Mullerian agenesis]] | |[[Mullerian agenesis]] | ||
Line 142: | Line 142: | ||
| | | | ||
|Normal | |Normal | ||
|XX | |[[XX]] | ||
|- | |- | ||
|[[Ovarian insufficiency|Primary ovarian insufficiency]] | |[[Ovarian insufficiency|Primary ovarian insufficiency]] | ||
Line 154: | Line 154: | ||
|High | |High | ||
|High | |High | ||
|XX | |[[XX]] | ||
|- | |- | ||
|[[Hypogonadotropic hypogonadism]] | |[[Hypogonadotropic hypogonadism]] | ||
| | | | ||
* Functional, | * Functional, sellar masses | ||
| | | | ||
* Normal [[female genitalia]], | * Normal [[female genitalia]], | ||
Line 168: | Line 168: | ||
|Low | |Low | ||
|Normal | |Normal | ||
|XX | |[[XX]] | ||
|- | |- | ||
|[[Turner syndrome]] | |[[Turner syndrome]] | ||
Line 180: | Line 180: | ||
|High | |High | ||
|High | |High | ||
|XO | |[[XO]] | ||
|} | |} | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} |
Revision as of 14:43, 7 August 2017
17 alpha-hydroxylase deficiency Microchapters |
Differentiating 17 alpha-hydroxylase deficiency from other Diseases |
Diagnosis |
Treatment |
Case Studies |
17 alpha-hydroxylase deficiency differential diagnosis On the Web |
American Roentgen Ray Society Images of 17 alpha-hydroxylase deficiency differential diagnosis |
FDA on 17 alpha-hydroxylase deficiency differential diagnosis |
CDC on 17 alpha-hydroxylase deficiency differential diagnosis |
17 alpha-hydroxylase deficiency differential diagnosis in the news |
Blogs on 17 alpha-hydroxylase deficiency differential diagnosis |
Risk calculators and risk factors for 17 alpha-hydroxylase deficiency differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mehrian Jafarizade, M.D [2]
Overview
17 alpha-hydroxylase deficiency must be differentiated from other diseases that cause similar clinical features, such as 5-alpha-reductase deficiency and hypogonadism
Differentiating 17 alpha-hydroxylase deficiency from other Diseases
17 alpha-hydroxylase deficiency must be differentiated from diseases with primary amenorrhea, in female phenotype. These diseases include Pregnancy, androgen insensitivity syndrome, 3-beta-hydroxysteroid dehydrogenase type 2 deficiency, 17-alpha-hydroxylase deficiency, gonadal dysgenesis, testicular regression syndrome, LH receptor defects, 5-alpha-reductase type 2 deficiency, mullerian agenesis
, [1]
Disease name | Cause | Differentiating | ||||||
---|---|---|---|---|---|---|---|---|
Findings | Uterus | Breast development | Testosterone | LH | FSH | Karyotyping | ||
Pregnancy | HCG positive | |||||||
3-beta-hydroxysteroid dehydrogenase type 2 deficiency |
|
Yes in female | Yes in female | Low | Normal | Normal | XY and XX | |
17-alpha-hydroxylase deficiency |
|
No | No | Low | Normal | Normal | XY | |
Gonadal dysgenesis |
|
|
Yes | Yes | Low | High | High | XY |
Testicular regression syndrome |
|
|
No | No | Low | High | High | XY |
LH receptor defects |
|
No | No | High | High | XY | ||
5-alpha-reductase type 2 deficiency |
|
No | No | High to normal | High to normal | XY | ||
Androgen insensitivity syndrome |
|
|
No | Yes | Normal male range | XY | ||
Mullerian agenesis |
|
No | Yes | Normal female range | Normal | XX | ||
Primary ovarian insufficiency |
|
|
Yes | Yes | Normal female range | High | High | XX |
Hypogonadotropic hypogonadism |
|
|
Yes | No | Normal female range | Low | Normal | XX |
Turner syndrome |
|
|
Yes | Yes | Normal female range | High | High | XO |
References
- ↑ Maimoun L, Philibert P, Cammas B, Audran F, Bouchard P, Fenichel P, Cartigny M, Pienkowski C, Polak M, Skordis N, Mazen I, Ocal G, Berberoglu M, Reynaud R, Baumann C, Cabrol S, Simon D, Kayemba-Kay's K, De Kerdanet M, Kurtz F, Leheup B, Heinrichs C, Tenoutasse S, Van Vliet G, Grüters A, Eunice M, Ammini AC, Hafez M, Hochberg Z, Einaudi S, Al Mawlawi H, Nuñez CJ, Servant N, Lumbroso S, Paris F, Sultan C (2011). "Phenotypical, biological, and molecular heterogeneity of 5α-reductase deficiency: an extensive international experience of 55 patients". J. Clin. Endocrinol. Metab. 96 (2): 296–307. doi:10.1210/jc.2010-1024. PMID 21147889.